Decay kinetics of HIV-1-RNA in seminal plasma with dolutegravir/lamivudine versus dolutegravir plus emtricitabine/tenofovir alafenamide in treatment-naive people living with HIV

BACKGROUND: This was a substudy of a Phase IV, randomized clinical trial (ClinicalTrials.gov identifier: NCT04295460) aiming to compare the activity of dolutegravir/lamivudine versus dolutegravir plus tenofovir alafenamide/emtricitabine (DTG + TAF/FTC) in the male genital tract. METHODS: Participant...

Descripción completa

Detalles Bibliográficos
Autores principales: Saborido-Alconchel, Abraham, Serna-Gallego, Ana, Lopez-Cortes, Luis E, Trujillo-Rodriguez, María, Praena-Fernandez, Juan Manuel, Dominguez-Macias, Montserrat, Lozano, Carmen, Muñoz-Muela, Esperanza, Espinosa, Nuria, Roca-Oporto, Cristina, Sotomayor, Cesar, Herrero, Marta, Gutierrez-Valencia, Alicia, Lopez-Cortes, Luis F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477137/
https://www.ncbi.nlm.nih.gov/pubmed/37545387
http://dx.doi.org/10.1093/jac/dkad245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477137/
https://www.ncbi.nlm.nih.gov/pubmed/37545387
http://dx.doi.org/10.1093/jac/dkad245

Ejemplares similares